Results for tag: "Retinal Edema Drug"

The Retinal Edema Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat a variety of eye conditions. Retinal edema is a condition in which fluid accumulates in the retina, causing swelling and impairing vision. Retinal edema drugs are used to reduce swelling and improve vision. These drugs are typically administered as injections, and may be used in combination with other treatments such as laser therapy. Commonly used retinal edema drugs include anti-VEGF agents, corticosteroids, and carbonic anhydrase inhibitors. The Retinal Edema Drug market is highly competitive, with a number of companies offering products for the treatment of retinal edema. Some of the major players in the market include Regeneron Pharmaceuticals, Allergan, Novartis, Roche, and Bayer. Show Less Read more